Latest Orexo (ORXOF) Headlines Orexo AB announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Orexo (ORXOF) Headlines

Orexo AB announces conversion of convertible bonds into shares
M2 - Mon Aug 26, 6:17AM CDT
Speciality pharmaceutical company Orexo AB (STO:ORX.ST) announced today the conversion of a convertible bond issue, subscribed by Novo A/S, into shares on 23 August 2013.

U.S. FDA Approves Zubsolv® for the Maintenance Treatment of Opioid Dependence
PR Newswire - Fri Jul 05, 7:00AM CDT
Orexo U.S., Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zubsolv (buprenorphine and naloxone) sublingual tablets (CIII). Zubsolv is indicated for the maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support. Zubsolv is a once-daily, sublingual tablet with higher bioavailability, a fast dissolve time, smaller tablet size and a new menthol flavor.

Orexo's Zubsolv receives US FDA approval
M2 - Thu Jul 04, 10:55AM CDT
Specialty pharmaceutical company Orexo AB (STO:ORX.ST) announced today the receipt of approval from the US Food and Drug Administration (FDA) for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.

Acute Pain - Pipeline Review, H1 2013
M2 - Fri Apr 05, 7:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gdw5kx/acute_pain) has announced the addition of the "Acute Pain - Pipeline Review, H1 2013" report to their offering. 'Acute Pain - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Pain. Acute Pain - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Acute Pain. - Identi

2 Bio Stock Reports: (NASDAQ: GALE), (NASDAQ: ARRY)
ACCESSWIRE-TNW - Tue Mar 26, 2:20AM CDT
New York (March 26th, 2013) - Galena Biopharma, Inc. (NASDAQ: GALE) announced last week that it has entered into an agreement with Orexo AB (ORX.ST), an emerging specialty pharmaceutical company based in Sweden, to acquire Abstral(R) (fentanyl) Sublingual Tablets for sale and distribution in the United States.

2 BIO Stocks in the News: (NASDAQ: GALE), (NYSE: NAVB)
ACCESSWIRE-TNW - Tue Mar 19, 12:22AM CDT
New York (March 19th, 2013) - Galena Biopharma, Inc. (NASDAQ: GALE) announced it has entered into an agreement with Orexo AB (ORX.ST), an emerging specialty pharmaceutical company based in Sweden, to acquire Abstral(R) (fentanyl) Sublingual Tablets for sale and distribution in the United States.

Orexo sells Abstral in the US to Galena Biopharma for USD10m upfront
M2 - Mon Mar 18, 1:40PM CDT
Speciality pharma company Orexo AB (STO:ORX.ST) announced today the sale of Abstral (fentanyl) sublingual tablets in the US to Galena Biopharma Inc (Nasdaq:GALE), a biopharmaceutical company.

Orexo AB announces divestiture of Abstral in the US for USD10m upfront
M2 - Mon Mar 18, 6:50AM CDT
Specialist pharma company Orexo AB (Stockholm:ORX.ST) revealed on Monday the sale of its FDA approved Abstral (fentanyl) Sublingual Tablets in the US to Galena Biopharma, Inc (NasdaqCM:GALE) for USD10m upfront .

Migraine - Pipeline Review, H1 2013
M2 - Tue Mar 12, 7:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wqgjw4/migraine) has announced the addition of Global Markets Direct's new report "Migraine - Pipeline Review, H1 2013" to their offering. Global Markets Direct's, 'Migraine - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Migraine, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Migraine. Migraine - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Scope - A snapshot of the global therapeutic scenario for Migraine. - A review of the Mi

Orexo names Nikolaj Sorensen as new CEO and Martin Nicklasson as Executive Chairman
M2 - Tue Feb 05, 5:08AM CST
Specialty pharmaceutical company Orexo AB (STO:ORX.ST) today announced that Nikolaj Sorensen, currently chief commercial officer of Orexo, will be promoted as CEO of the company.

Orexo AB. (ORXOF) Stock Research Links

ORXOF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ouma Connect Streamlines Surrogacy Medical Clearance

Updated Category News Views 161

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 75

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
CPSC's Management Overhaul: Progress or Just Polishing?

Updated Category News Views 60

The Tangled Web of Bureaucracy Ah, the Consumer Product Safety Commission—CPSC for short. It's like the Secretariat of product safety, but often knee-deep in old problems. Over the years, hearing about their challenges is like flipping through a well-worn playbook. But now, the talk is all about a fresh page under Acting Chairman Peter A. Feldman. The watchdog in...

Continue Reading
Docusign and SAP Team Up for Seamless Business Flow

Updated Category News Views 124

Docusign Brings Its A-Game with SAP Partnership Waking up to find Docusign (NASDAQ:DOCU) teaming up with SAP is like getting a surprise deal at the Saturday market—unexpected but welcome. These two giants in their respective fields are joining forces to plant Docusign’s Intelligent Agreement Management (IAM) directly into SAP Sales Cloud and SAP SuccessFactors. If...

Continue Reading
FL Technics Indonesia Expands with EASA Certification

Updated Category News Views 100

Bali's Skies Just Got a Major Upgrade Picture this: You've got a sprawling 17,000 square meter facility sitting pretty at I Gusti Ngurah Rai International Airport, nestled in the paradise locale of Bali. What's next? It's now flexing some serious muscles with its newfound EASA Part-145 certification, allowing it to tackle aircraft registered in the European Union. This is...

Continue Reading
Decoding the Risks and Rewards of Older Homes

Updated Category News Views 54

Cracking Open the Older Homes Enigma You've got these older homes—charm oozing out of every nook and cranny but potential pitfalls hidden beneath every surface. I'm talking about that irresistible lure of historic details that come with a side of risk. Now, before you jump in with both feet, you might want to pause and consider what Lee Malcom from Malcom & Malcom...

Continue Reading
Natural Field Reinvents Supplement Delivery at SupplySide

Updated Category News Views 35

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Continue Reading
Retlaw Industries Acquired by AIM Processing in Major Deal

Updated Category News Views 29

Retlaw's Big Move in the Plastics Game In the sprawling world of plastics, some might say each piece tells a story—not unlike this latest saga with Retlaw Industries, Inc. and AIM Processing. Picture Wisconsin's Retlaw, nestled in the heart of manufacturing, recently shaking hands with fellow molder AIM Processing. This isn't just a neighborly team-up; it's a power play...

Continue Reading
Reimagining Water: A Crisis and a Call to Action

Updated Category News Views 121

Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...

Continue Reading
Duke Energy's Battle Against Energy Vampires Heats Up

Updated Category News Views 104

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Continue Reading

Top 5 Most Recently Viewed Articles

Financial 15 Split Corp. Plans Normal Course Issuer Bid

Updated Category News Views 108

Announcement of Normal Course Issuer Bid Financial 15 Split Corp. has made a significant announcement regarding its plans to strengthen shareholder value through a Normal Course Issuer Bid (NCIB) following the acceptance by the Toronto Stock Exchange (TSX). This initiative aims to buy back certain classes of shares, primarily focusing on the company's Preferred Shares and...

Continue Reading
NUH Reinvents Healthcare with Green Innovations

Updated Category News Views 42

Award-Winning Green Healthcare from NUH The National University Hospital (NUH) in Singapore is making waves and cleaning the air at the same time. It's racked up a shiny Gold Award at the 2026 International Hospital Federation (IHF) Awards for its Green Operating Theatre programme — and folks, it's not just any old clap on the back. This is low-carbon healthcare in...

Continue Reading
NutraBio Unveils PROTEIN NOW!™: 21g Protein Shot

Updated Category News Views 18

NutraBio Enters the Convenient Protein Arena A hot July day, but my mind's firmly focused on protein. NutraBio Labs, the folks who’ve been pushing nutrition boundaries for over three decades, have rolled out something to shake things up— and I ain't talking about powder shakes. PROTEIN NOW!™ is stepping in with a mighty claim: 21 grams of protein, zero sugar, zero...

Continue Reading
AI and Unified Solutions Revolutionizing Australia’s Workspaces

Updated Category News Views 302

AI and Unified Solutions Transform Australia's Workplaces A dynamic shift is occurring within Australian enterprises as they increasingly adopt artificial intelligence (AI) and advanced analytics. These innovations are successfully integrating into digital workplace solutions, giving companies the edge they need to enhance productivity and remain competitive. Recent...

Continue Reading
WeRide Inc. Sets Price for Initial Public Offering at $15.50

Updated Category News Views 233

WeRide Inc. Pricing Details for Initial Public Offering WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD), a pioneer in the autonomous driving realm, recently revealed the pricing of its initial public offering (IPO). In this offering, the company will issue 7,742,400 American depositary shares (ADSs), where each share represents three of WeRide's Class A...

Continue Reading